deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT03101358

Study of Topical SOR007 Ointment for Cutaneous Metastases

Phase 1/2 Dose-Rising, Safety, Tolerability and Efficacy Study of Topical SOR007 for Cutaneous Metastases

Sponsor: NanOlogy, LLC

Conditions Cutaneous Metastasis
Interventions SOR007 (Uncoated Nanoparticle Paclitaxel) Ointment
Updated 15 times since 2017 Last updated: Nov 3, 2021 Started: Jan 31, 2018 Primary completion: Apr 29, 2020 Completion: Apr 29, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Cutaneous Metastasis and is currently completed. NanOlogy, LLC leads this study, which shows 15 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~May 2017 – ~Aug 2017 · 3 months · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~Nov 2017 · 2 months · monthly snapshot~Nov 2017 – ~Mar 2018 · 4 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Apr 2020 · 11 months · monthly snapshot~Apr 2020 – ~Oct 2020 · 6 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 10 earlier versions

  1. Apr 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  2. May 2019 — Apr 2020 [monthly]

    Recruiting PHASE1_PHASE2

  3. Feb 2019 — May 2019 [monthly]

    Recruiting PHASE1_PHASE2

  4. Aug 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1_PHASE2

  6. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  7. Nov 2017 — Mar 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    Phase: PHASE2 → PHASE1_PHASE2

  8. Sep 2017 — Nov 2017 [monthly]

    Not Yet Recruiting PHASE2

  9. Aug 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE2

  10. May 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • NanOlogy, LLC
  • US Biotest, Inc.
Data source: NanOlogy, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations